Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases
Authors:
- Marleen I. VerstegeMVMarleen I. Verstege
- Esther W.M. VogelsEVEsther W.M. Vogels
- Sander MeisnerSMSander Meisner
- Caroline VerseijdenCVCaroline Verseijden
- Pieter C.F. StokkersPSPieter C.F. Stokkers
- Anje A. Te VeldeAVAnje A. Te Velde
- 1 August 2012
- journal article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (8) , 965-970
Abstract
Background and Aim The balance between microbes and host defence mechanisms at the mucosal frontier plays an important, yet unclarified role in the pathogenesis of inflammatory bowel disease (IBD). The importance of microorganisms in IBD is supported by the association of IBD with mutations in pattern recognition receptors (PRRs) such as NOD2 and TLR4. We aimed to examine whether polymorphisms in another type of PRRs, the so-called C-type lectin receptors (CLRs), are associated with IBD. Growing insights into the pathogenetic role of NOD2 mutations in Crohn's disease (CD) and the fact that the majority of CLR-encoding genes are located in IBD susceptibility loci provide strong arguments for further exploration of the role of CLRs in IBD. Methods In this study, we selected four single nucleotide polymorphisms (SNPs) in different CLRs to determine whether there could be a role for these CLRs in IBD. Functional SNPs in the genes coding for the candidate CLRs DC-SIGN, LLT1, DCIR and MGL were examined. Genotyping of all SNPs was performed at the Academic Medical Center. In this study, around 1572 samples were included from a maximum of 621 CD patients, 457 ulcerative colitis (UC) patients and 586 healthy controls (HCs). Results and conclusion No association was found between our IBD cohort and the candidate SNPs for DC-SIGN (CD/HC: P=0.25 and UC/HC: P=0.36), DCIR CD/HC: P=0.22 and UC/HC: P=0.41) and MGL (CD/HC: P=0.37 and UC/HC: P=0.25). However, one polymorphism in LLT1 was found to be associated with our CD population (P <0.034). Our UC cohort was not associated with the variation in LLT1 (P=0.33). LLT1 is a ligand for the recently discovered CD161. CD161 is a new surface marker for human interleukin (IL)-17-producing Th17 cells. The Th17 phenotype has been linked to CD by the fact that IL-22, IL-17 and IL-23 receptor levels are increased in CD. The signal transduction pathways involving LLT1 and CD161 are not completely clarified and are currently under investigation in our laboratory. Eur J Gastroenterol Hepatol 24:965-970 (c) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & WilkinKeywords
This publication has 40 references indexed in Scilit:
- Induction of Lectin-like Transcript 1 (LLT1) Protein Cell Surface Expression by Pathogens and Interferon-γ Contributes to Modulate Immune ResponsesJournal of Biological Chemistry, 2011
- The Dectin-2 family of C-type lectins in immunity and homeostasisCytokine, 2009
- Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15− Crohn's disease patientsEuropean Journal of Human Genetics, 2009
- Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammationJournal of Experimental Medicine, 2009
- Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursorJournal of Experimental Medicine, 2008
- CD209 in inflammatory bowel disease: a case-control study in the Spanish populationBMC Medical Genetics, 2007
- Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cellsJournal of Dermatological Science, 2007
- Neisseria meningitidis expressing lgtB lipopolysaccharide targets DC-SIGN and modulates dendritic cell functionCellular Microbiology, 2006
- The LLT1 receptor induces IFN-γ production by human natural killer cellsMolecular Immunology, 2004
- C-type lectin receptors on dendritic cells and langerhans cellsNature Reviews Immunology, 2002